Read articles from Europe

September 03, 2026 by snusforumet.se

The gateway theory has shaped nicotine policy for years, often turning vaping into a presumed pathway to smoking rather than a potential route away from it. Challenging that assumption matters because policy should follow observed behaviour, not fears repeated until they sound like evidence. Research that separates correlation from causation can help clarify whether safer nicotine products are driving harm or displacing cigarettes. Public health needs that distinction before it builds restrictions around a theory.

September 03, 2026 by clearingtheair.eu

Tobacco control loses credibility when opposition to industry turns into opposition to harm reduction itself. Cigarette companies deserve scrutiny, but that does not make every argument for safer nicotine products a tobacco industry tactic. Adult smokers are poorly served by a debate that treats reduced-risk options as contamination rather than opportunity. Public health should be able to reject industry misconduct while still recognising evidence that helps people move away from combustion.

September 02, 2026 by worldvapersalliance.com

The US approach to nicotine pouches shows a more practical way to handle smoke-free innovation. Rather than treating the category as a threat by default, regulators can assess products through evidence, standards and their potential role in moving adults away from cigarettes. Europe should not fall behind by regulating pouches as though all nicotine use carries the same public health meaning. A risk-proportionate framework would protect young people while allowing lower-risk alternatives to compete with combustible tobacco.

September 02, 2026 by planetofthevapes.co.uk

Expert reaction to the latest Cochrane findings should move the vaping debate closer to clinical reality. Nicotine vapes have stronger evidence for helping people quit smoking than many critics are willing to acknowledge, especially for adults who have struggled with other methods. That does not make vaping risk-free or suitable for non-smokers. It means cessation advice should reflect the evidence clearly enough to help smokers leave combustion behind.

September 01, 2026 by tidsskriftet.no

Changing nicotine preferences do not necessarily indicate a shrinking nicotine market. They can mean a shift in how people consume nicotine: away from cigarettes and towards pouches, snus, vaping or heated tobacco. That distinction matters because public health outcomes depend on the form of use, not only the presence of nicotine itself. A stable market can still become less harmful when policy helps consumers move away from combustion.

September 01, 2026 by realclearhealth.com

A regulator can make quitting harder even while claiming to protect public health. Delayed approvals, narrow authorisation pathways and hostility towards safer nicotine products can leave adult smokers with fewer legal options than they need. Cigarettes remain widely available while alternatives that may help people switch face barriers that slow or block access. The FDA’s approach should be judged by whether it reduces smoking-related harm, not by how cautious it appears on paper.

September 01, 2026 by euractiv.com

The Swedish election has turned EU tobacco taxation into a question of political timing, but the public health issue remains unresolved. Taxing cigarettes and smoke-free nicotine products too closely risks erasing the price signal that can help smokers move away from combustion. Sweden’s position reflects more than national preference; it raises the question of whether Europe is willing to tax according to risk. A credible Tobacco Excise Directive should discourage smoking without making lower-risk alternatives less competitive.

August 28, 2026 by daily-pouch.com

Public trust is not lost all at once; it erodes through exaggeration, inconsistency and messages that do not match lived experience. In nicotine policy, that damage grows when adults are told to quit smoking but are denied clear, proportionate information about lower-risk alternatives. Once public health sounds more interested in control than honesty, people start looking elsewhere for answers. Rebuilding trust means being accurate about risk, transparent about uncertainty and respectful of the people policy is meant to help.

August 28, 2026 by substack.com

A JAMA article supporting clinician conversations about e-cigarettes should make the debate more precise. The evidence is strongest for adult smokers who use vaping as a route away from cigarettes, not for vague claims about nicotine use in general. That distinction matters because policy can either support full switching or bury it under uncertainty. Medical guidance should separate evidence from values clearly enough for smokers to understand their options.

August 28, 2026 by planetofthevapes.co.uk

New Zealand’s quit success shows what happens when smokers are given practical routes away from cigarettes. Vaping has played a visible role in accelerating the shift from combustion, especially for adults who need more than willpower or repeated warnings. The lesson is not that every policy can be copied wholesale, but that access, affordability and honest risk communication matter. Smoking falls faster when lower-risk alternatives are treated as tools, not threats.